×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Institute of Ch... [13]
THE STATE KEY LA... [7]
Faculty of Healt... [4]
Authors
WANG YITAO [6]
LU JINJIAN [4]
LEUNG CHUNG HANG [3]
CHEN XIUPING [3]
LEE MING YUEN [2]
CHEN MEIWAN [2]
More...
Document Type
Journal article [16]
Conference paper [1]
Date Issued
2024 [1]
2023 [1]
2022 [2]
2020 [1]
2018 [2]
2017 [1]
More...
Language
英語English [15]
Source Publication
Molecular Pharma... [2]
ONCOTARGET [2]
APPLIED MICROBIO... [1]
Applied Microbio... [1]
European Journal... [1]
International Jo... [1]
More...
Indexed By
SCIE [14]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-10 of 17
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Submit date Ascending
Submit date Descending
Author Ascending
Author Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Title Ascending
Title Descending
WOS Cited Times Ascending
WOS Cited Times Descending
A glycyrrhetinic acid-iridium(III) conjugate as a theranostic NIR probe for hepatocellular carcinoma with mitochondrial-targeting ability
Journal article
Wang, Ling, Wang, Xueliang, Chen, Feng, Song, Ying Qi, Nao, Sang Cuo, Chan, Daniel Shiu Hin, Wong, Chun Yuen, Wang, Wanhe, Leung, Chung Hang. A glycyrrhetinic acid-iridium(III) conjugate as a theranostic NIR probe for hepatocellular carcinoma with mitochondrial-targeting ability[J]. European Journal of Medicinal Chemistry, 2024, 264, 115995.
Authors:
Wang, Ling
;
Wang, Xueliang
;
Chen, Feng
;
Song, Ying Qi
;
Nao, Sang Cuo
; et al.
Favorite
|
TC[WOS]:
3
TC[Scopus]:
3
IF:
6.0
/
6.1
|
Submit date:2024/02/22
Glycyrrhetinic Acid (Ga)
Hepatocellular Carcinoma
Iridium(Iii) Complex
Mitochondrial Targeting
Nir Imaging
Theranostic
Glycyrrhetinic acid suppresses breast cancer metastasis by inhibiting M2-like macrophage polarization via activating JNK1/2 signaling
Journal article
Yanfen Cheng, Xuemei Zhong, Xin Nie, Huan Gu, Xiaoping Wu, Renkai Li, Yihan Wu, Kongpeng Lv, George Pak-Heng Leung, Chaomei Fu, Simon Ming-Yuen Lee, Jinming Zhang, Jingjing Li. Glycyrrhetinic acid suppresses breast cancer metastasis by inhibiting M2-like macrophage polarization via activating JNK1/2 signaling[J]. Phytomedicine, 2023, 114, 154757.
Authors:
Yanfen Cheng
;
Xuemei Zhong
;
Xin Nie
;
Huan Gu
;
Xiaoping Wu
; et al.
Favorite
|
TC[WOS]:
20
TC[Scopus]:
19
IF:
6.7
/
6.2
|
Submit date:2023/07/27
Angiogenesis
Breast Cancer Metastasis
Glycyrrhetinic Acid
Jnk1/2 Pathway
Tumor-associated Macrophages
Natural compound glycyrrhetinic acid protects against doxorubicin-induced cardiotoxicity by activating the Nrf2/HO-1 signaling pathway
Journal article
Cheng, Yanfen, Wu, Xiaoping, Nie, Xin, Wu, Yihan, Zhang, Chen, Lee, Simon Ming Yuen, Lv, Kongpeng, Leung, George Pak Heng, Fu, Chaomei, Zhang, Jinming, Li, Jingjing. Natural compound glycyrrhetinic acid protects against doxorubicin-induced cardiotoxicity by activating the Nrf2/HO-1 signaling pathway[J]. PHYTOMEDICINE, 2022, 106.
Authors:
Cheng, Yanfen
;
Wu, Xiaoping
;
Nie, Xin
;
Wu, Yihan
;
Zhang, Chen
; et al.
Favorite
|
TC[WOS]:
36
TC[Scopus]:
45
IF:
6.7
/
6.2
|
Submit date:2022/12/01
Cardiotoxicity
Doxorubicin
Glycyrrhetinic Acid
Nrf2
Oxidative Stress
Glycyrrhizic Acid and Its Derivatives: Promising Candidates for the Management of Type 2 Diabetes Mellitus and Its Complications
Journal article
Tan, Dechao, Tseng, Hisa Hui Ling, Zhong, Zhangfeng, Wang, Shengpeng, Vong, Chi Teng, Wang, Yitao. Glycyrrhizic Acid and Its Derivatives: Promising Candidates for the Management of Type 2 Diabetes Mellitus and Its Complications[J]. International Journal of Molecular Sciences, 2022, 23(19), 10988.
Authors:
Tan, Dechao
;
Tseng, Hisa Hui Ling
;
Zhong, Zhangfeng
;
Wang, Shengpeng
;
Vong, Chi Teng
; et al.
Favorite
|
TC[WOS]:
20
TC[Scopus]:
23
|
Submit date:2022/11/07
Glycyrrhizic Acid
Glycyrrhetinic Acid
Ammonium Glycyrrhizinate
Diammonium Glycyrrhizinate
Type 2 Diabetes Mellitus
Diabetic Complications
Insulin Resistance
Glucose Tolerance
Dietary compound glycyrrhetinic acid suppresses tumor angiogenesis and growth by modulating antiangiogenic and proapoptotic pathways in vitro and in vivo
Journal article
Li,Jingjing, Tang,Fan, Li,Renkai, Chen,Zhejie, Lee,Simon Ming Yuen, Fu,Chaomei, Zhang,Jinming, Leung,George Pak Heng. Dietary compound glycyrrhetinic acid suppresses tumor angiogenesis and growth by modulating antiangiogenic and proapoptotic pathways in vitro and in vivo[J]. Journal of Nutritional Biochemistry, 2020, 77.
Authors:
Li,Jingjing
;
Tang,Fan
;
Li,Renkai
;
Chen,Zhejie
;
Lee,Simon Ming Yuen
; et al.
Favorite
|
TC[WOS]:
31
TC[Scopus]:
33
IF:
4.8
/
5.4
|
Submit date:2021/03/01
Antiangiogenesis
Apoptosis
Dietary Compound
Glycyrrhetinic Acid
Ovarian Cancer
Characteristics and molecular determinants of a highly selective and efficient glycyrrhizin-hydrolyzing beta-glucuronidase from Staphylococcus pasteuri 3I10
Journal article
Wei, Bin, Wang, Pan-Pan, Yan, Zhi-Xiang, Yan, Ru. Characteristics and molecular determinants of a highly selective and efficient glycyrrhizin-hydrolyzing beta-glucuronidase from Staphylococcus pasteuri 3I10[J]. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2018, 102(21), 9193-9205.
Authors:
Wei, Bin
;
Wang, Pan-Pan
;
Yan, Zhi-Xiang
;
Yan, Ru
Favorite
|
TC[WOS]:
20
TC[Scopus]:
20
IF:
3.9
/
4.9
|
Submit date:2019/01/17
Staphylococcus Pasteuri
Bacterial Beta-glucuronidase
Glycyrrhizin
Glycyrrhetinic Acid
Deglucuronidation
Homology Modeling
Characteristics and molecular determinants of a highly selective and efficient glycyrrhizin-hydrolyzing β-glucuronidase from Staphylococcus pasteuri 3I10
Journal article
Bin Wei, Pan-Pan Wang, Zhi-Xiang Yan, Ru Yan. Characteristics and molecular determinants of a highly selective and efficient glycyrrhizin-hydrolyzing β-glucuronidase from Staphylococcus pasteuri 3I10[J]. Applied Microbiology and Biotechnology, 2018, 102(21), 9193–9205.
Authors:
Bin Wei
;
Pan-Pan Wang
;
Zhi-Xiang Yan
;
Ru Yan
Favorite
|
TC[WOS]:
20
TC[Scopus]:
20
IF:
3.9
/
4.9
|
Submit date:2019/01/15
Staphylococcus Pasteuri
Β-glucuronidases
Deglucuronidation
Glycyrrhizin
Glycyrrhetinic Acid
Homology Modeling
Gut Microbiota
Cleavable Multifunctional Targeting Mixed Micelles with Sequential pH-Triggered TAT Peptide Activation for Improved Antihepatocellular Carcinoma Efficacy
Journal article
Zhang, Jinming, Zheng, Yifeng, Xie, Xi, Wang, Lan, Su, Ziren, Wang, Yitao, Leong, Kam W., Chen, Meiwan. Cleavable Multifunctional Targeting Mixed Micelles with Sequential pH-Triggered TAT Peptide Activation for Improved Antihepatocellular Carcinoma Efficacy[J]. MOLECULAR PHARMACEUTICS, 2017, 14(11), 3644-3659.
Authors:
Zhang, Jinming
;
Zheng, Yifeng
;
Xie, Xi
;
Wang, Lan
;
Su, Ziren
; et al.
View
|
Adobe PDF
|
Favorite
|
TC[WOS]:
29
TC[Scopus]:
31
IF:
4.5
/
4.6
|
Submit date:2018/10/30
Tumor-targeting
Glycyrrhetinic Acid
Ph-sensitive
Tat Exposure
Mixed Micelles
Codelivery of Doxorubicin and shAkt1 by Poly(ethylenimine)-Glycyrrhetinic Acid Nanoparticles to Induce Autophagy-Mediated Liver Cancer Combination Therapy
Journal article
Feng-Zhen Wang, Lei Xing, Zheng-hai Tang, Jin-Jian Lu, Peng-Fei Cui, Jian-Bing Qiao, Lei Jiang, Hu-Lin Jiang, Li Zong. Codelivery of Doxorubicin and shAkt1 by Poly(ethylenimine)-Glycyrrhetinic Acid Nanoparticles to Induce Autophagy-Mediated Liver Cancer Combination Therapy[J]. Molecular Pharmaceutics, 2016, 13(4), 1298-1307.
Authors:
Feng-Zhen Wang
;
Lei Xing
;
Zheng-hai Tang
;
Jin-Jian Lu
;
Peng-Fei Cui
; et al.
Favorite
|
TC[WOS]:
54
TC[Scopus]:
53
|
Submit date:2018/12/28
Autophagy
Combination Therapy
Glycyrrhetinic Acid
Liver Cancer Targeting
Self-assembled
Codelivery of Doxorubicin and shAkt1 by Poly ethylenimine)−Glycyrrhetinic Acid Nanoparticles To Induce Autophagy-Mediated Liver Cancer Combination Therapy
Journal article
Wang, FZ, Xing, L, Tang, ZH, Lu, J., Cui, PF, Qiao, JB, Jiang, L, Jiang, HL, Zhong, L. Codelivery of Doxorubicin and shAkt1 by Poly ethylenimine)−Glycyrrhetinic Acid Nanoparticles To Induce Autophagy-Mediated Liver Cancer Combination Therapy[J]. Molecular Pharmaceutics, 2016, 1298-1307.
Authors:
Wang, FZ
;
Xing, L
;
Tang, ZH
;
Lu, J.
;
Cui, PF
; et al.
Favorite
|
IF:
4.5
/
4.6
|
Submit date:2022/08/26
combination therapy
self-assembled
glycyrrhetinic acid
liver cancer targeting
autophagy